and is also in trials for Crohn’s and primary biliary cholangitis. Meanwhile, there are drugs in other classes jostling for market share for UC, including biologics like TNF inhibitors and ...

Tepezza was recently approved in Japan for treatment of active or high clinical activity score thyroid eye disease ... For example, primary biliary cholangitis drug seladelpar has gained ...

The retinal pigment epithelial sheet that had been transplanted survived well, and the corrected visual acuity of the treated eye did not improve ... The etiology of biliary atresia, primary biliary ...

Livdelzi (seladelpar) is a medicine that can treat primary biliary cholangitis (PBC) by reducing the amount of bile in your body. It does this by signaling the body to stop making bile acid.

Gilead Sciences’ Livdelzi (seladelpar) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat adults with the rare liver disease primary biliary cholangitis (PBC) ...

Medically reviewed by Jay N. Yepuri, MD Primary sclerosing cholangitis (PSC) is a progressive scarring of the liver's bile ...

Ipsen has been given accelerated approval by the FDA for Iqirvo, which becomes the first dual PPAR alpha/delta agonist for rare cholestatic liver disease primary biliary cholangitis (PBC).

topline data expected in 2026 Volixibat VANTAGE study in primary biliary cholangitis (PBC) expected to complete enrollment in 2026 LIVMARLI EXPAND Phase 3 study for pruritus in rare cholestatic ...

Your primary ... Untreated biliary colic can lead to serious complications such as gallbladder inflammation, bile duct inflammation, jaundice (yellow-tinted skin and eyes), and pancreatitis ...

Primary biliary cirrhosis (PBC ... and primary sclerosing cholangitis (PSC). The most frequent ANA patterns in PBC sera are the 'speckled' (Figure 1), the multiple nuclear dots (MND; Figure ...